The global tracheostomy products market size is expected to reach USD 887.5 million by 2033, registering a CAGR of 4.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. The volume of surgical operations has increased with the rising incidence of chronic respiratory illnesses, such as Cardiovascular Diseases (CVDs), diabetes, respiratory diseases, cancer, or other respiratory injuries. As the number of surgeries conducted worldwide continues to rise, the demand for tracheostomy products is growing at a rapid pace. During the COVID-19 pandemic, the FDA had undertaken steps to ensure prompt access to high-quality medical devices for healthcare providers and patients to respond effectively to a public health emergency.
Therefore, the Emergency Use Authorization (EUA) regulatory strategy aids several enterprises in expanding the availability of respiratory products and accessories. Smiths Medical (U.S.) introduced Portex tracheostomy tubes and kits in January 2020. In COVID-19 patients, tracheostomy is being used to aid with weaning and maximizing healthcare resource usage. Respiratory disorders continue to be more prevalent in economies with middle and low income. According to the WHO, the higher the prevalence of pollution and cigarette usage, the greater the risk of respiratory disorders in the years ahead. This has resulted in the increased need for respiratory accessories, such as tracheostomy products. Asthma affects around 334 million people worldwide and it is the most prevalent chronic illness observed during childhood, impacting around 14% of children.
The lack of experienced professionals and the post-operative risks associated with laparoscopy operations are restricting the market growth. However, several market players are expected to introduce novel, advanced, as well as ergonomically designed upgraded products in the market over the forecast period, creating potential prospects for the market across the globe. North America dominated the global market, in terms of revenue share, in 2021 owing to the rapid development of innovative technologies and therapies for throat cancer and the presence of advanced healthcare infrastructure. However, Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the rising incidence of COPD and other chronic respiratory illnesses.
Request a free sample copy or view the report summary: Tracheostomy Products Market Report
By product type, tracheostomy tubes held the largest revenue share of 32.5% in 2025. The speaking valves (one-way valves) segment is anticipated to grow at the fastest CAGR over the forecast period.
By procedure type, the percutaneous tracheostomy held the largest revenue share of 53.8% in 2025. Surgical tracheostomy is also witnessing significant growth due to its continued clinical importance in complex and high-risk cases where anatomical challenges, emergency airway access, or contraindications to percutaneous techniques exist.
By demographics, the adult segment held the largest revenue share of 84.5% in 2025. The pediatric segment is witnessing significant growth due to increasing survival rates of premature infants and children with complex congenital or neurological conditions who require long-term airway support.
By indication, the chronic ventilation held the largest revenue share of 37.3% in 2025. Neurological disorder is the fastest-growing indication segment.
By end-use, the hospitals (ICU, operating rooms) held the largest revenue share of 77.2% in 2025. Home healthcare is the fastest-growing end-use segment due to the increasing shift toward long-term, post-acute, and chronic respiratory care outside hospital settings.
Grand View Research has segmented global tracheostomy products market report based on product type, procedure type, demographics, indication, end-use, and region:
Tracheostomy Products Product Type Outlook (Revenue, USD Million, 2021 - 2033)
Tracheostomy Tubes
By Cuff Type
Cuffed
Uncuffed
By Design
Fenestrated
Non-fenestrated
Percutaneous Tracheostomy Kits
Cannula
Single Cannula
Inner Cannula
Speaking Valves (One-way Valves)
Humidification Systems (Heat & Moisture Exchangers (HMEs))
Accessories & Consumables
Tube holders/ties
Dressings
Suction kits
Cleaning kits
Tracheostomy Products Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
Surgical Tracheostomy
Percutaneous Tracheostomy
Tracheostomy Products Demographics Outlook (Revenue, USD Million, 2021 - 2033)
Adult
Pediatric
Neonatal
Tracheostomy Products Indication Outlook (Revenue, USD Million, 2021 - 2033)
Chronic ventilation
Airway obstruction
Neurological disorders
Emergency airway access
Others
Tracheostomy Products End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals (ICU, Operating Rooms)
Long-Term Care Facilities
Home Healthcare
Tracheostomy Products Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
India
China
Japan
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Tracheostomy Products Market
Medtronic
Teleflex Incorporated
ICU Medical (Smiths Medical)
Fisher & Paykel Healthcare
Cardinal Health
Well Lead Medical
Fuji Systems Corporation
ConvaTec Group
Boston Medical Products
Sewoon Medical
Pulmodyne (Intersurgical Group)
Andersen Products
Cook Medical
Atos Medical (Coloplast)
Romsons
Angiplast Private Limited
Cruzine
Sterimed Group
Vitaltec Corporation
AdvaCare Pharma
SCW Medicath Ltd
Röchling SE & Co. KG
Medis Medical (UK) Ltd
Primed Halberstadt Medizintechnik GmbH
TuoRen Medical
Vygon
Global Medikit
Dynarex Corporation (Medline)
Andreas Fahl Medizintechnik-Vertrieb GmbH
Intersurgical Ltd
Fogless International
Sumi
"The quality of research they have done for us has been excellent..."